Overview

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

Status:
Recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
This study will evaluate maternal tolerance to several BUP dose reduction strategies.
Phase:
Phase 2
Details
Lead Sponsor:
Steve N. Caritis, MD
University of Pittsburgh
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
Buprenorphine